Original Research

Original Research

Delirium and Mortality in COVID-19 Patients

August 21, 2023

COVID-19 patients with early onset delirium had a 2-fold increased mortality risk—both in-hospital and after discharge—than those without delirium.

Original Research

Adjunctive Cariprazine for MDD With Inadequate Response to Antidepressants

August 16, 2023

This study assessed the efficacy of adjunctive use of cariprazine, an atypical antipsychotic, in MDD patients with inadequate response to antidepressants.

Original Research

Fiscal Impact of Schizophrenia From a Government Perspective

August 9, 2023

This analysis revealed that the lifetime fiscal loss to the government was $1,540,042 for each person with schizophrenia.

Original Research

Antihypertensive Medications and PTSD

August 2, 2023

Calcium channel blockers were linked to decreased incidence of PTSD; the association was not found for any other antihypertensive medication classes.

Original Research

The NIMH Research Portfolio: An Update

August 1, 2023

NIMH has continued to prioritize basic research over clinical trials, resulting in a decline in funding for possible treatments for psychiatric diseases.

Original Research

Hepatitis C Screening and Treatment in Psychiatry Inpatients

July 31, 2023

Of people admitted to a psychiatric unit, 4.9% had a positive HCV antibody screening result, underlining the need to screen psychiatric inpatients for hepatitis C.